Search

Your search keyword '"García-Sicilia, José"' showing total 21 results

Search Constraints

Start Over You searched for: Author "García-Sicilia, José" Remove constraint Author: "García-Sicilia, José"
21 results on '"García-Sicilia, José"'

Search Results

1. Comparative study of journal selection criteria used by MEDLINE and EMBASE, and their application to Spanish biomedical journals

2. Anamnestic Immune Response and Safety of an Inactivated Quadrivalent Influenza Vaccine in Primed Versus Vaccine-Naïve Children

3. Assessment of an optimized manufacturing process for inactivated quadrivalent influenza vaccine: a phase III, randomized, double-blind, safety and immunogenicity study in children and adults

4. Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine Candidate: A Phase III Randomized Controlled Trial in Children

6. Immunogenicity and Safety of Human Papillomavirus-16/18 AS04-Adjuvanted Cervical Cancer Vaccine Coadministered With Combined Diphtheria-Tetanus-Acellular Pertussis–inactivated Poliovirus Vaccine to Girls and Young Women

7. Impact of maternal diphtheria-tetanus-acellular pertussis vaccination on pertussis booster immune responses in toddlers: Follow-up of a randomized trial

8. Additional file 3: of Assessment of an optimized manufacturing process for inactivated quadrivalent influenza vaccine: a phase III, randomized, double-blind, safety and immunogenicity study in children and adults

9. Additional file 2: of Assessment of an optimized manufacturing process for inactivated quadrivalent influenza vaccine: a phase III, randomized, double-blind, safety and immunogenicity study in children and adults

10. Additional file 1: of Assessment of an optimized manufacturing process for inactivated quadrivalent influenza vaccine: a phase III, randomized, double-blind, safety and immunogenicity study in children and adults

11. Five-year Antibody Persistence and Safety Following a Booster Dose of Combined Haemophilus influenzae Type b–Neisseria meningitidis Serogroup C–Tetanus Toxoid Conjugate Vaccine

13. Immunogenicity and Reactogenicity of a Booster Dose of a Novel Combined Haemophilus influenzae Type b-Neisseria meningitidis Serogroup C-Tetanus Toxoid Conjugate Vaccine Given to Toddlers of 13–14 Months of Age With Antibody Persistence Up to 31 Months of Age

14. Immunogenicity and Reactogenicity of Primary Immunization With a Novel Combined Haemophilus influenzae Type b and Neisseria meningitidis Serogroup C-Tetanus Toxoid Conjugate Vaccine Coadministered With a Diphtheria–Tetanus–Acellular Pertussis–Hepatitis B–Inactivated Poliovirus Vaccine at 2, 4 and 6 Months

15. Immunogenicity and Reactogenicity of a Three-Dose Primary Vaccination Course With a Combined Diphtheria-Tetanus-Acellular Pertussis-Hepatitis B-Inactivated Polio-Haemophilus influenzae Type b Vaccine Coadministered With a Meningococcal C Conjugate Vaccine

16. Five-year Antibody Persistence and Safety Following a Booster Dose of Combined Haemophilus influenzaeType b–Neisseria meningitidisSerogroup C–Tetanus Toxoid Conjugate Vaccine

17. Immunogenicity and Reactogenicity of a Booster Dose of a Novel Combined Haemophilus influenzaeType b-Neisseria meningitidisSerogroup C-Tetanus Toxoid Conjugate Vaccine Given to Toddlers of 13–14 Months of Age With Antibody Persistence Up to 31 Months of Age

18. Immunogenicity and Reactogenicity of Primary Immunization With a Novel Combined Haemophilus influenzaeType b and Neisseria meningitidisSerogroup C-Tetanus Toxoid Conjugate Vaccine Coadministered With a Diphtheria–Tetanus–Acellular Pertussis–Hepatitis B–Inactivated Poliovirus Vaccine at 2, 4 and 6 Months

19. Immunogenicity and Reactogenicity of a Three-Dose Primary Vaccination Course With a Combined Diphtheria-Tetanus-Acellular Pertussis-Hepatitis B-Inactivated Polio-Haemophilus influenzaeType b Vaccine Coadministered With a Meningococcal C Conjugate Vaccine

20. ANTIBODY PERSISTENCE AFTER PRIMARY VACCINATION WITH A HEXAVALENT DTPa-HBV-IPV/HIB VACCINE COADMINISTERED WITH A MENINGOCOCCAL C-CRM197VACCINE AND RESPONSE TO A DTPa-IPV/HIB BOOSTER AT 18 MONTHS OF AGE

21. Antibody persistence after primary vaccination with a hexavalent DTPa-HBV-IPV/HiB vaccine coadministered with a meningococcal C-CRM197 vaccine and response to a DTPa-IPV/HiB booster at 18 months of age.

Catalog

Books, media, physical & digital resources